PCSK9 and hyperlipidemia: As previously reviewed [63], the expression of miR-27a, miR-140-5p, miR-191, miR-222, miR-224, miR-378a-3p, miR-140-5p, miR-483, and miR-520d-5p modulates pathogenesis of hyperlipidemia by targeting proprotein convertase subtilisin/kexin type 9 (PCSK9).